Soft tissue fillers and biofilms

Facial Plastic Surgery

Volumn 27, Issue 1, 2011, Pages 23-28

  Dayan, Steven H ^a,b   Arkins, John P ^c   Brindise, Renata ^d  

^a Chicago Center for Facial Plastic Surgery   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c DeNova Research   (United States)

^d MIDWESTERN UNIVERSITY   (United States)

Author keywords

adverse event; biofilm; complications; Filler; hypersensitivity reaction

Indexed keywords

BIOMATERIAL;

ARTICLE; BIOFILM; DELAYED HYPERSENSITIVITY; DIFFERENTIAL DIAGNOSIS; ESTHETIC SURGERY; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INFECTION; MICROBIOLOGY;

BIOCOMPATIBLE MATERIALS; BIOFILMS; COSMETIC TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; PROSTHESIS-RELATED INFECTIONS;

EID: 78751678368     PISSN: 07366825     EISSN: 10988793     Source Type: Journal    
DOI: 10.1055/s-0030-1270415     Document Type: Article

References (47)

1. Sage R J., Chaffins M L., Kouba D J. Granulomatous foreign body reaction to hyaluronic acid: report of a case after melolabial fold augmentation and review of management. Dermatol Surg 2009 35 Suppl 2 1696-1700
2. Narins R S., Jewell M, Rubin M, Cohen J, Strobos J. Clinical conference: management of rare events following dermal fillersfocal necrosis and angry red bumps. Dermatol Surg 2006 32 426-434
3. Friedman P M., Mafong E A., Kauvar A N., Geronemus R G. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 2002 28 491-494
4. Raulin C, Greve B, Hartschuh W, Soegding K. Exudative granulomatous reaction to hyaluronic acid (Hylaform). Contact Dermat 2000 43 178-179
5. Fernández-Aceñero M J., Zamora E, Borbujo J. Granulomatous foreign body reaction against hyaluronic acid: report of a case after lip augmentation. Dermatol Surg 2003 29 1225-1226
6. Lupton J R., Alster T S. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg 2000 26 135-137
7. Cohen J L. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg 2008 34 Suppl 1 S92-S99
8. Gell P GH, Coombs R RA, Lachmann P J. Clinical Aspects of Immunology. 3rd ed. Philadelphia, PA Blackwell Scientific Publications 1975
9. Patel V J., Bruck M C., Katz B E. Hypersensitivity reaction to hyaluronic acid with negative skin testing. Plast Reconstr Surg 2006 117 92e-94e
10. Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 2005 29 34-48
11. Rothschild L J., Mancinelli R L. Life in extreme environments. Nature 2001 409 1092-1101
12. Donlan R M., Costerton J W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002 15 167-193
13. Narins R S., Dayan S H., Brandt F S., Baldwin E K. Persistence and improvement of nasolabial fold correction with nonanimal-stabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: results up to 18 months on two retreatment schedules. Dermatol Surg 2008 34 Suppl 1 S2-S8 discussion S8
14. Flaharty P. Radiance. Facial Plast Surg 2004 20 165-169
15. Alijotas-Reig J, Garcia-Gimenez V. Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long-term follow-up and review of the literature. J Eur Acad Dermatol Venereol 2008 22 150-161
16. Bellman B. Immediate and delayed hypersensitivity reactions to restylane. Aesthet Surg J 2005 25 489-491
17. De Boulle K. Management of complications after implantation of fillers. J Cosmet Dermatol 2004 3 2-15
18. Lombardi T, Samson J, Plantier F, Husson C, Küffer R. Orofacial granulomas after injection of cosmetic fillers. Histopathologic and clinical study of 11 cases. J Oral Pathol Med 2004 33 115-120
19. Angus J E., Affleck A G., Leach I H., Millard L G. Two cases of delayed granulomatous reactions to the cosmetic filler Dermalive, a hyaluronic acid and acrylic hydrogel. Br J Dermatol 2006 155 1077-1078
20. Ghislanzoni M, Bianchi F, Barbareschi M, Alessi E. Cutaneous granulomatous reaction to injectable hyaluronic acid gel. Br J Dermatol 2006 154 755-758
21. Wolfram D, Tzankov A, Piza-Katzer H. Surgery for foreign body reactions due to injectable fillers. Dermatology 2006 213 300-304
22. Al-Shraim M, Jaragh M, Geddie W. Granulomatous reaction to injectable hyaluronic acid (Restylane) diagnosed by fine needle biopsy. J Clin Pathol 2007 60 1060-1061
23. Sidwell R U., Dhillon A P., Butler P E., Rustin M H. Localized granulomatous reaction to a semi-permanent hyaluronic acid and acrylic hydrogel cosmetic filler. Clin Exp Dermatol 2004 29 630-632
24. Mamelak A J., Katz T M., Goldberg L H., Graves J J., Kaye V N., Friedman P M. Foreign body reaction to hyaluronic acid filler injection: in search of an etiology. Dermatol Surg 2009 35 Suppl 2 1701-1703
25. Sankar V, McGuff H S. Foreign body reaction to calcium hydroxylapatite after lip augmentation. J Am Dent Assoc 2007 138 1093-1096
26. Vleggaar D. Soft-tissue augmentation and the role of poly-L-lactic acid. Plast Reconstr Surg 2006 118 3, Suppl 46S-54S
27. Lam S M., Azizzadeh B, Graivier M. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg 2006 118 3, Suppl 55S-63S
28. Bentkover S H. The biology of facial fillers. Facial Plast Surg 2009 25 73-85
29. Lemperle G, Gauthier-Hazan N, Wolters M, Eisemann-Klein M, Zimmermann U, Duffy D M. Foreign body granulomas after all injectable dermal fillers: part 1. Possible causes. Plast Reconstr Surg 2009 123 1842-1863
30. Christensen L H. Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers. Dermatol Surg 2009 35 Suppl 2 1612-1619
31. Christensen L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg 2007 33 Suppl 2 S168-S175
32. Shafir R, Amir A, Gur E. Long-term complications of facial injections with Restylane (injectable hyaluronic acid). Plast Reconstr Surg 2000 106 1215-1216
33. Brody H J. Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement. Dermatol Surg 2005 31 8 Pt 1 893-897
34. Matarasso S L., Herwick R. Hypersensitivity reaction to nonanimal stabilized hyaluronic acid. J Am Acad Dermatol 2006 55 128-131
35. Cox S E. Clinical experience with filler complications. Dermatol Surg 2009 35 Suppl 2 1661-1666
36. Hönig J F., Brink U, Korabiowska M. Severe granulomatous allergic tissue reaction after hyaluronic acid injection in the treatment of facial lines and its surgical correction. J Craniofac Surg 2003 14 197-200
37. Dijkema S J., van der Lei B, Kibbelaar R E. New-fill injections may induce late-onset foreign body granulomatous reaction. Plast Reconstr Surg 2005 115 76e-78e
38. Ceri H, Olson M E., Stremick C, Read R R., Morck D, Buret A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999 37 1771-1776
39. Anwar H, Strap J L., Chen K, Costerton J W. Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin. Antimicrob Agents Chemother 1992 36 1208-1214
40. Bjarnsholt T, Tolker-Nielsen T, Givskov M, Janssen M, Christensen L H. Detection of bacteria by fluorescence in situ hybridization in culture-negative soft tissue filler lesions. Dermatol Surg 2009 35 Suppl 2 1620-1624
41. Pecharki D, Petersen F C., Scheie A A. Role of hyaluronidase in Streptococcus intermedius biofilm. Microbiology 2008 154 Pt 3 932-938
42. Jayaraman A, Wood T K. Bacterial quorum sensing: signals, circuits, and implications for biofilms and disease. Annu Rev Biomed Eng 2008 10 145-167
43. Cassuto D, Marangoni O, De Santis G, Christensen L. Advanced laser techniques for filler-induced complications. Dermatol Surg 2009 35 Suppl 2 1689-1695
44. Yagi Y, Kato K, Murakami D et al. Use of Aquamid as a filler for facial rejuvenation in orientals. J Plast Reconstr Aesthet Surg 2009 62 1245-1249
45. Moadab A, Rupley K F., Wadhams P. Effectiveness of a nonrinse, alcohol-free antiseptic hand wash. J Am Podiatr Med Assoc 2001 91 288-293
46. Attila C, Ueda A, Wood T K. 5-Fluorouracil reduces biofilm formation in Escherichia coli K-12 through global regulator AriR as an antivirulence compound. Appl Microbiol Biotechnol 2009 82 525-533
47. Nyhlén A, Ljungberg B, Nilsson-Ehle I, Odenholt I. Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli. Chemotherapy 2002 48 71-77